SCHEMBL4687860

SCHEMBL4687860

NC(=O)c1ccc(OCCO)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.46
MAPK1 P28482 2/20 0.45
SLC6A4 P31645 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
TP53 P04637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 4/20 0.43
CHEK2 O96017 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687791 0.92 MAPK1 (0.49) MRGPRX4MAPK1SLC6A4SLC6A2SLC6A3
SCHEMBL6131023 0.85 NPC1 (0.56) MRGPRX4NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL25781022 0.83 THRA (0.50) MRGPRX4MAPK1SLC6A4SLC6A2SLC6A3
SCHEMBL25780651 0.83 THRA (0.50) MRGPRX4MAPK1SLC6A4SLC6A2SLC6A3
SCHEMBL28383737 0.83 THRA (0.49) MRGPRX4MAPK1NPC1HPGDRAB9A
SCHEMBL4464186 0.82 MAPK1 (0.67) MAPK1SLC6A4SLC6A2SLC6A3NPC1
SCHEMBL4827025 0.81 MAPT (0.50) MRGPRX4MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL7783936 0.81 SLC6A4 (0.43) MRGPRX4MAPK1SLC6A4SLC6A2SLC6A3
SCHEMBL4684232 0.81 MAPK1 (0.49) MAPK1SLC6A4SLC6A2SLC6A3SMN1; SMN2
SCHEMBL4025985 0.81 MAPK1 (0.65) MAPK1TP53CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed